Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Cash And Cash Equivalents At Carrying Value of $8.27 million for the year ending 2025.
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -2.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
- XBRL data for this metric is available from 2011 to 2025 (24 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 24 years of available data (2011 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Cash And Cash Equivalents At Carrying Value has grown by 1.6%.
- Historical annual values: Fiscal year 2025: $8.27 million | Fiscal year 2024: $8.46 million | Fiscal year 2023: $19.09 million | Fiscal year 2023: $2.95 million | Fiscal year 2022: $5.94 million | Fiscal year 2022: $2.54 million | Fiscal year 2022: $991.0 thousand | Fiscal year 2022: $1.10 million | Fiscal year 2021: $609.0 thousand | Fiscal year 2021: $939.0 thousand | Fiscal year 2021: $763.0 thousand | Fiscal year 2021: $1.85 million | Fiscal year 2020: $2.48 million | Fiscal year 2020: $439.0 thousand | Fiscal year 2020: $360.0 thousand | Fiscal year 2019: $1.08 million | Fiscal year 2018: $2.90 million | Fiscal year 2017: $6.00 million | Fiscal year 2016: $9.97 million | Fiscal year 2015: $14.13 million | Fiscal year 2014: $14.24 million | Fiscal year 2013: $13.72 million | Fiscal year 2012: $22.18 million | Fiscal year 2011: $8.14 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: